Loading...
XNYS
TDOC
Market cap1.66bUSD
Jul 09, Last price  
9.21USD
1D
1.54%
1Q
80.59%
Jan 2017
-44.18%
IPO
-67.11%
Name

Teladoc Health Inc

Chart & Performance

D1W1MN
XNYS:TDOC chart
P/E
P/S
0.66
EPS
Div Yield, %
Shrs. gr., 5y
14.25%
Rev. gr., 5y
18.26%
Revenues
2.53b
-1.54%
19,906,00043,528,00077,384,000123,157,000233,279,000417,907,000553,307,0001,093,962,0002,032,707,0002,406,840,0002,602,415,0002,569,574,0002,529,977,000
Net income
-200m
L-79.99%
-6,019,000-17,037,000-58,020,000-74,216,000-106,782,000-97,084,000-98,864,000-485,136,000-428,793,000-13,659,531,000-220,368,000-1,001,245,000-200,322,000
CFO
294m
+0.23%
-6,053,000-11,359,000-47,181,000-51,795,000-34,441,000-4,860,00029,869,000-53,511,000193,990,000189,292,000350,021,000293,680,000294,357,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Teladoc Health, Inc. offers remote medical services to individuals both domestically in the United States and internationally. Their extensive range of solutions covers a wide array of health needs, from routine and acute conditions to complex and long-term illnesses such as diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and various mental health issues. The company delivers numerous programs, including virtual primary and specialized medical care, management for chronic diseases, expert second opinion services, mental wellness support, and core platform and service offerings. They serve a diverse client base, including corporations, health insurance providers, hospitals and healthcare systems, financial service companies, and individual patients. The Teladoc, Livongo, and BetterHelp brands fall under their purview. Founded in 2002, the company, which operated as Teladoc, Inc. until its renaming in August 2018, is based in Purchase, New York.
IPO date
Jul 01, 2015
Employees
4,816
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT